The Sculptique Aesthetics
BPC-157 Peptide Dosage Guide: Complete Injectable, Oral & Healing Protocols (Mumbai 2026)
BPC-157 dosage for every goal — injectable vs oral, injury healing, gut health, joint pain and post-surgical recovery. Exact dose ranges, reconstitution maths, cycling, side effects and medically supervised protocols from The Sculptique Aesthetics Mumbai.

BPC-157 dosage is the single variable that separates a protocol that heals from one that disappoints. BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide — 15 amino acids — originally derived from a protein found in human gastric juice. In clinical and research settings it is used for tendon, ligament, muscle and gut repair. Get the dose, route and goal aligned correctly and results appear within 2–3 weeks. Get any one of those wrong and you waste both product and time.
If you're searching for BPC-157 dosage, how much BPC-157 to inject, BPC-157 dose for injury healing, BPC-157 dose for gut health, BPC-157 injectable vs oral, or BPC-157 dosage for tendon repair, this guide covers every protocol in clinical use. The Sculptique Aesthetics offers BPC-157 and peptide therapy under medical supervision in Mumbai, Bandra, Khar, Andheri, South Mumbai and across India.
This is an educational reference. We do not recommend self-sourcing or self-dosing BPC-157. Every protocol is individualised at consultation.
What is BPC-157 and why does dose matter?
BPC-157 (Body Protection Compound-157) signals tissue repair through multiple simultaneous pathways — angiogenesis (new blood vessel growth), growth factor upregulation (VEGF, EGF), fibroblast migration, anti-inflammatory action and nitric oxide modulation. Unlike many compounds that work through a single receptor, BPC-157 is a pleiotropic healer — it restores tissue environment rather than simply suppressing inflammation.
BPC-157 dosage matters because:
- Below the therapeutic threshold (~100–150 mcg/day for most goals), cellular signalling is too weak to drive meaningful repair
- Above the plateau (~750–1,000 mcg/day), the response curve flattens — you're spending more for diminishing returns
- Route of administration dramatically changes the effective dose: oral BPC-157 reaches gut tissue exceptionally well (unusual for a peptide) but distributes poorly systemically; subcutaneous injection gives systemic coverage; intramuscular injection near an injury gives the highest local concentration
See are peptides safe and what do peptides do for context.
BPC-157 dosage — the key numbers
Standard injectable BPC-157 dose: 250–500 mcg per injection, twice daily = 500 mcg – 1 mg total per day
- Conservative / beginner dose: 250 mcg once daily
- Standard healing dose: 250–500 mcg twice daily (morning + evening, 12 hours apart)
- Intensive / acute injury dose: 500 mcg twice daily (1 mg/day total)
- Maintenance / wellness dose: 250 mcg once daily
- Upper research range: 750 mcg twice daily (rarely used; reserved for severe acute injuries)
Oral BPC-157 dose: 500 mcg – 1 mg once daily, on an empty stomach. Oral works well for gut and digestive goals; less effective for systemic injury healing.
Body-weight-based dosing guide (used when greater precision is needed):
- Low (maintenance/prevention): 2–3 mcg/kg/day
- Standard (injury/healing): 4–5 mcg/kg/day
- High (acute/severe): 6–7 mcg/kg/day
For a 70 kg patient: standard dose = 280–350 mcg per injection; high dose = 420–490 mcg per injection.
BPC-157 reconstitution: the maths you must get right
BPC-157 typically arrives as a lyophilised powder in 5 mg or 10 mg vials. Before injecting you must reconstitute with bacteriostatic water (never plain sterile water — no preservative means the solution degrades in days).
Concentration formula: mg/ml = total mg ÷ ml of water added
Common reconstitution scenarios:
| Vial size | Water added | Concentration | 250 mcg dose | 500 mcg dose |
|---|---|---|---|---|
| 5 mg | 2 ml | 2,500 mcg/ml | 0.10 ml (10 units) | 0.20 ml (20 units) |
| 5 mg | 5 ml | 1,000 mcg/ml | 0.25 ml (25 units) | 0.50 ml (50 units) |
| 10 mg | 5 ml | 2,000 mcg/ml | 0.125 ml (12.5 units) | 0.25 ml (25 units) |
How long does a 5 mg BPC-157 vial last?
- At 250 mcg twice daily (500 mcg/day) → 10 days
- At 500 mcg twice daily (1 mg/day) → 5 days
- At 250 mcg once daily (250 mcg/day) → 20 days
Refrigerate reconstituted solution at 2–8 °C and use within 28–30 days. Never freeze after reconstitution.
BPC-157 dosage by goal
Injury healing — tendons, ligaments and muscles
The most common application. BPC-157 reaches injured connective tissue, upregulates growth factors and drives fibroblast proliferation.
- Dose: 250–500 mcg twice daily SC or IM
- Injection site: near injury when possible (within 5–10 cm), or systemic abdominal for systemic distribution
- Duration: 4–8 weeks for acute injuries; 8–12 weeks for chronic or severe injuries
- Cycle: 8–12 weeks on, 4–8 weeks off
- Stacking: pairs exceptionally with TB-500 — see the GLOW / Wolverine stack below and our BPC-157 & TB-500 recovery guide
Results timeline: noticeable improvement at 2–3 weeks; significant healing at 4–6 weeks; full tissue remodelling over 8–12 weeks.
Gut health — IBS, leaky gut, ulcers, reflux
BPC-157 shows remarkable gut-healing effects and — uniquely among peptides — maintains reasonable oral bioavailability for gut applications because the target tissue is the gut wall itself.
- Oral protocol (preferred): 500 mcg – 1,000 mcg once daily, on an empty stomach (30 minutes before food or 2 hours after)
- Injectable protocol (alternative): 250–500 mcg SC twice daily, systemic (abdomen)
- Duration: 6–12 weeks; chronic gut conditions may need 3–6 months
- Cycle: continuous with monthly review; break after 12 weeks
Joint pain and osteoarthritis
- Dose: 250–500 mcg SC twice daily
- Injection site: near the affected joint where possible; systemic abdominal otherwise
- Duration: 6–10 weeks
- Expected improvement: reduced inflammation and pain in 2–4 weeks; improved range of motion over 6–8 weeks
Post-surgical recovery
- Dose: 500 mcg SC twice daily
- Timing: start day 1–3 post-surgery (with clinician approval)
- Duration: throughout recovery period, minimum 4–6 weeks
- Stacking: GHK-Cu + BPC-157 + TB-500 (GLOW stack) for maximal tissue quality post-surgery
General wellness and prevention
- Dose: 250 mcg SC once daily
- Frequency: 5 days on / 2 days off or daily
- Cycle: 4 weeks on, 2 weeks off, repeated
- Goal: systemic tissue maintenance, gut lining health, joint lubrication
BPC-157 dosage quick-reference table
| Goal | Route | Dose per injection | Frequency | Duration |
|---|---|---|---|---|
| Acute injury (tendon/ligament) | SC near injury | 500 mcg | Twice daily | 4–8 weeks |
| Standard healing | SC near injury or systemic | 250–500 mcg | Twice daily | 8–12 weeks |
| Gut healing | Oral | 500–1,000 mcg | Once daily (empty stomach) | 6–12 weeks |
| Joint pain | SC near joint | 250–500 mcg | Twice daily | 6–10 weeks |
| Post-surgical | SC systemic | 500 mcg | Twice daily | 4–6 weeks |
| Prevention / wellness | SC systemic | 250 mcg | Once daily | 4-week cycles |
Ranges are from research protocols. Your individual dose is set at consultation at The Sculptique Aesthetics.
Injectable vs oral BPC-157: which to choose?
Injectable BPC-157 is the gold standard for systemic and localised healing — it reaches musculoskeletal tissue, joints and organs directly.
Oral BPC-157 is best for gut-specific goals (IBS, leaky gut, reflux, ulcers). The peptide's unusual gastric resistance means meaningful amounts survive digestion. Oral is convenient, requires no needles and suits patients who cannot or will not inject.
Rule of thumb:
- Injury, joint, surgery, systemic: inject
- Gut, digestive, lower GI: oral works, injection is an alternative
- Both: injectable systemic + oral can be combined without dose adjustment
BPC-157 and TB-500: the Wolverine / GLOW stack
BPC-157 and TB-500 target tissue repair through complementary mechanisms. BPC-157 drives local growth factor expression and fibroblast activity. TB-500 (Thymosin Beta-4 fragment) regulates actin, promotes cell migration systemically and reduces chronic inflammation.
Standard Wolverine stack protocol:
- BPC-157: 250–500 mcg SC twice daily, near injury or systemic
- TB-500: 2–2.5 mg SC twice weekly during loading (weeks 1–4), then 2 mg once weekly maintenance (weeks 5–12)
- Do NOT mix in the same vial — inject separately in the same session or hours apart
Adding GHK-Cu makes this the GLOW stack — the most comprehensive tissue repair protocol we use. See BPC-157 & TB-500 recovery guide and GHK-Cu dosage guide.
Injection technique: subcutaneous vs intramuscular
Subcutaneous (SC): most common, safest, and effective for both local and systemic goals. Inject into the fatty tissue of the abdomen, thigh, or arm. Short insulin needle (29–31 gauge, 6–8 mm). Pinch skin, insert at 45°, release skin, inject slowly.
Intramuscular (IM): used when higher local concentration near deep soft tissue is needed. Clinician-administered at The Sculptique Aesthetics for joint and deep tendon applications. Requires longer needle and confirmed anatomical knowledge — do not attempt without training.
Injection site for BPC-157: for injury-specific use, injecting within 5–10 cm of the affected structure improves local peptide concentration. For systemic or gut goals, any SC site works equally well.
Timing and schedule
Best time of day for BPC-157:
- Twice-daily protocol: morning (fasted or with food — food doesn't affect SC absorption) + evening, 12 hours apart
- Once-daily protocol: morning or evening — choose whichever you'll stick to consistently
- Oral BPC-157 for gut: morning on an empty stomach, 30 minutes before breakfast
Cycling:
- Standard: 8–12 weeks on, 4–8 weeks off
- Preventive: 4 weeks on, 2 weeks off, repeat indefinitely
- Acute injury: run continuously until resolution, then add 1–2 weeks maintenance before stopping
Consistency drives results more than perfect timing. Link administration to an existing daily habit.
BPC-157 dosing mistakes we see at our Mumbai clinic
- Underdosing. Using 1 mg/day spread over four micro-doses instead of 500 mcg twice daily. The delivery pattern matters as much as the total — consistent bolus doses drive more signalling.
- Oral dosing for a muscle injury. Oral BPC-157 distributes into gut tissue, not musculoskeletal tissue. Inject for injuries.
- Injecting with plain sterile water. No bacteriostatic preservative = contaminated solution within days. Always use bacteriostatic water.
- Stopping too soon. Feeling better at 3 weeks is not healed — connective tissue remodelling takes weeks beyond the point of symptom relief. Complete the full protocol.
- Self-sourcing unverified product. We see injection-site infections and dosing errors from unregulated online vials regularly. Medical-grade product, prescribed and supervised at The Sculptique Aesthetics. See are peptides available in India.
- Not addressing the underlying cause. BPC-157 accelerates healing; it does not correct overtraining, poor biomechanics or nutritional deficiency. Combine with appropriate rest and rehabilitation.
Side effects and safety
BPC-157 has one of the strongest safety profiles of any research peptide — no serious adverse events have been reported in animal studies even at very high doses. In clinical practice:
Common, mild and typically transient
- Injection site redness or mild swelling — resolves within hours; rotate sites
- Mild nausea — occasional, usually with oral forms; take with small amount of food if persistent
- Dizziness or headache — rare, usually first 1–2 injections; reduce dose temporarily
- Vivid dreams — reported by some users; not harmful
Theoretical concerns
- Tumour concerns: animal studies show no pro-tumorigenic effect; some data suggest BPC-157 may actually inhibit certain cancer pathways. However, standard precaution: pause BPC-157 if you have an active malignancy until more human data exists.
- Hormonal effects: no significant effect on testosterone, oestrogen or cortisol at standard doses
Who should avoid BPC-157
- Active malignancy (precautionary)
- Pregnancy and breastfeeding
- Anyone unable to maintain sterile injection technique (source clinic-administered doses instead)
See are peptides safe for a broader peptide safety discussion.
Storage and shelf life
- Lyophilised powder (unreconstituted): freeze at -20 °C; stable for 2+ years; store away from light
- Reconstituted solution: refrigerate at 2–8 °C; use within 28–30 days; never freeze after mixing
- Oral capsules / liquid: room temperature; follow product labelling; refrigerate after opening if in doubt
Frequently asked questions
250–500 mcg subcutaneously, twice daily (12 hours apart), for 8–12 weeks. Total daily dose of 500 mcg – 1 mg. Start at the lower end (250 mcg twice daily) and increase to 500 mcg twice daily if needed after 2 weeks.
Oral: 500 mcg – 1,000 mcg once daily, on an empty stomach. Oral BPC-157 works especially well for gut-specific goals because the target tissue is the gut wall itself. Injectable is an alternative at 250–500 mcg twice daily SC.
Most suppliers provide 5 mg vials. At 250 mcg twice daily, one vial lasts 10 days. At 500 mcg twice daily, it lasts 5 days. A complete 8-week protocol at standard dose needs approximately 6–8 vials.
Acute injuries: noticeable improvement in 2–3 weeks; significant healing at 4–6 weeks. Chronic injuries or gut issues: 4–6 weeks for meaningful change; full benefit at 10–12 weeks. Do not judge results before 6 weeks minimum.
Yes — many patients do. Oral for gut support + injectable for a concurrent injury is a logical combination. No dose adjustment is required.
For localised injuries (tendon, ligament, muscle), injecting within 5–10 cm of the site improves local concentration. For systemic, gut or joint goals where injection near the site is impractical (knee, hip, spine), systemic abdominal injection works well. We guide injection site at consultation.
Yes — this is the Wolverine stack and one of the most effective healing protocols in clinical use. BPC-157 250–500 mcg SC twice daily + TB-500 2–2.5 mg SC twice weekly (loading), then 2 mg weekly (maintenance). Do not mix in the same vial. See BPC-157 & TB-500 recovery guide.
Continue with your next scheduled dose — do not double up. Single missed doses have negligible impact. Consistent patterns over weeks drive results, not any individual injection.
See are peptides available in India for the full context. At The Sculptique Aesthetics we source medical-grade BPC-157 through appropriate channels and administer it under clinical supervision.
No significant effect on testosterone, oestrogen or cortisol at standard doses. BPC-157 acts through local growth factor and nitric oxide pathways, not the hypothalamic-pituitary axis.
BPC-157 works primarily at the local injury site through growth factor upregulation and fibroblast stimulation — very targeted. TB-500 distributes systemically, regulating actin and promoting cell migration throughout the body. They complement each other perfectly for comprehensive healing. See BPC-157 & TB-500 recovery guide.
Building your personalised BPC-157 protocol in Mumbai
A well-built BPC-157 protocol follows a clear framework:
- Define the injury or goal — acute tendon, chronic gut issue, post-surgical, prevention
- Choose the route — injectable (most goals), oral (gut-specific), or combined
- Set the starting dose — 250 mcg twice daily for most; scale to 500 mcg twice daily if needed
- Choose injection site — near injury for localised goals; systemic for everything else
- Set cycle length — 8–12 weeks for healing; shorter for prevention
- Document baseline — pain scale, function test, range of motion; photograph where relevant
- Review at 4 weeks — adjust dose and cycle based on response
We run this process at The Sculptique Aesthetics with every BPC-157, TB-500 and combined healing protocol.
Book your BPC-157 consultation in Mumbai
Ready to move from injury or chronic gut issues to actual healing? Contact us at The Sculptique Aesthetics. We'll assess your injury, map it to the right BPC-157 dosage, injection technique and cycle length, and — where relevant — build the full Wolverine / GLOW stack with TB-500 and GHK-Cu for comprehensive tissue repair.
Serving patients across Mumbai, Bandra, Khar, Andheri, Powai, Juhu, South Mumbai and international patients travelling to India for medically supervised peptide therapy.








